Get startedLog in
    Picture of Venus Remedies logo

    VENUSREM — Venus Remedies News Story

    0.000.00%
    in flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapHigh Flyer
    All News

    India's Venus Remedies gains after renewal of in-house R&D recognition

    Picture of Venus Remedies logoVenus Remedies
    05/06/2026 05:06
    BUZZ-India's Venus Remedies gains after renewal of in-house R&D  recognition
    ** Shares of Venus Remedies VENR.NS rise to exchange-allowed maximum of 5% to 1,633.50 rupees
    ** Pharmaceuticals co secures renewal of in-house research & development recognition from the Department of Scientific and Industrial Research (DSIR)
    ** Adds, recognition supports Venus Medicine Research Centre's ongoing work in antimicrobial resistance, including development of VRP-034, a novel polymyxin B formulation
    ** YTD, VENR has more than doubled

     (Reporting by Vijay Malkar)
     ((VijayDattaram.Malkar@thomsonreuters.com;))

    Recent news on Venus Remedies

    See all news